The regulation of ginsenoside Rg1 upon aging of bone marrow stromal cell contribute to delaying senescence of bone marrow mononuclear cells (BMNCs)

Jul 29, 2018Life sciences

Ginsenoside Rg1 helps delay aging in bone marrow cells by affecting bone marrow support cells

AI simplified

Abstract

Rg1 significantly decreased the percentage of positive cell SA-Gal staining in bone marrow stromal cells (BMSCs) from an aging rat model.

  • Rg1 treatment reduced the effects of aging on BMSCs by lowering the rate of senescence-associated β-galactosidase (SA-Gal) positive cells.
  • Increased proliferative ability of BMSCs was observed after Rg1 treatment, indicating enhanced cell growth.
  • Co-culturing bone marrow nucleated cells (BMNCs) with Rg1-treated BMSCs led to a decreased apoptosis rate and improved mixed colony formation.
  • In BMNCs, Rg1 treatment resulted in reduced SA-Gal positive cell staining and enhanced colony-forming unit capacity.
  • Rg1 may restore hematopoietic capacity in BMNCs by counteracting aging effects through multiple pathways.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free